Huang Guo, the Deputy Director of the State Administration of Drug Regulation, conducted research on the management of raw materials in Zhejiang.

From November 13th to 14th, members of the Party group and deputy director of the National Medical Products Administration Huang Guo led a team to Zhejiang for research, held a special seminar on the management of raw materials for pharmaceuticals, visited raw material pharmaceutical production enterprises on site, and listened to opinions and suggestions from local drug regulatory authorities and raw material pharmaceutical production enterprises on the management of raw materials for pharmaceuticals and changes in the main registrants. Huang Guo stated that raw materials for pharmaceuticals are a key link in improving and strengthening the supply chain of the pharmaceutical industry, and it is necessary to attach great importance to and continuously optimize the supervision of raw materials for pharmaceuticals, actively respond to industry development demands, and continuously stimulate the innovation vitality of the industry. It is necessary to adhere to problem orientation, learn from international experience, and steadily promote the reform of the system for the supervision of raw materials for pharmaceuticals. We must strictly adhere to the safety bottom line, enhance the quality awareness of enterprises, and promote the high-quality development of the raw material pharmaceutical industry.